[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK1657310T3 - Fremgangsmåde til fremstilling af dihydroxyestere og derivater deraf - Google Patents

Fremgangsmåde til fremstilling af dihydroxyestere og derivater deraf

Info

Publication number
DK1657310T3
DK1657310T3 DK06002032T DK06002032T DK1657310T3 DK 1657310 T3 DK1657310 T3 DK 1657310T3 DK 06002032 T DK06002032 T DK 06002032T DK 06002032 T DK06002032 T DK 06002032T DK 1657310 T3 DK1657310 T3 DK 1657310T3
Authority
DK
Denmark
Prior art keywords
derivatives
preparation
dihydroxy esters
dihydroxy
esters
Prior art date
Application number
DK06002032T
Other languages
English (en)
Inventor
Robert Antony Holt
Christopher David Reeve
Andrew John Blacker
Original Assignee
Astrazeneca Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Uk Ltd filed Critical Astrazeneca Uk Ltd
Application granted granted Critical
Publication of DK1657310T3 publication Critical patent/DK1657310T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/041,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/061,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/03Preparation of carboxylic acid esters by reacting an ester group with a hydroxy group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C07C69/675Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids of saturated hydroxy-carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02Oxygen as only ring hetero atoms
    • C12P17/06Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/62Carboxylic acid esters

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK06002032T 2000-05-09 2001-05-01 Fremgangsmåde til fremstilling af dihydroxyestere og derivater deraf DK1657310T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0011120.3A GB0011120D0 (en) 2000-05-09 2000-05-09 Process
GB0011120 2001-05-01

Publications (1)

Publication Number Publication Date
DK1657310T3 true DK1657310T3 (da) 2007-10-29

Family

ID=9891211

Family Applications (3)

Application Number Title Priority Date Filing Date
DK01925699T DK1282719T3 (da) 2000-05-09 2001-05-01 Fremgangsmåde til fremstilling af dihydroxyestere og derivater deraf
DK06002032T DK1657310T3 (da) 2000-05-09 2001-05-01 Fremgangsmåde til fremstilling af dihydroxyestere og derivater deraf
DK06019415.6T DK1726658T3 (da) 2000-05-09 2001-05-01 Fremgangsmåde til fremstilling af dihydroxyestere og derivater deraf

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK01925699T DK1282719T3 (da) 2000-05-09 2001-05-01 Fremgangsmåde til fremstilling af dihydroxyestere og derivater deraf

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK06019415.6T DK1726658T3 (da) 2000-05-09 2001-05-01 Fremgangsmåde til fremstilling af dihydroxyestere og derivater deraf

Country Status (34)

Country Link
US (4) US7157255B2 (da)
EP (3) EP1282719B1 (da)
JP (1) JP4733901B2 (da)
KR (2) KR100914675B1 (da)
CN (1) CN1196793C (da)
AR (2) AR028074A1 (da)
AT (3) ATE330020T1 (da)
AU (2) AU5238301A (da)
BR (1) BR0110667A (da)
CA (2) CA2408004C (da)
CY (3) CY1105376T1 (da)
CZ (3) CZ302674B6 (da)
DE (3) DE60129865T2 (da)
DK (3) DK1282719T3 (da)
EE (1) EE05062B1 (da)
ES (3) ES2264981T3 (da)
GB (1) GB0011120D0 (da)
HK (3) HK1051708A1 (da)
HU (1) HUP0302216A3 (da)
IL (4) IL152608A0 (da)
IS (1) IS2290B (da)
MX (1) MXPA02010955A (da)
MY (1) MY127751A (da)
NO (1) NO20025377L (da)
NZ (1) NZ522407A (da)
PL (3) PL208377B1 (da)
PT (3) PT1726658E (da)
RU (1) RU2266961C2 (da)
SI (3) SI1657310T1 (da)
SK (2) SK287524B6 (da)
TW (1) TWI240753B (da)
UA (1) UA73774C2 (da)
WO (1) WO2001085975A1 (da)
ZA (1) ZA200208937B (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0011120D0 (en) * 2000-05-09 2000-06-28 Avecia Ltd Process
CA2380997A1 (en) * 2000-06-05 2001-12-13 Kaneka Corporation Process for preparing optically active 2-¬6-(hydroxy-methyl)-1,3-dioxan-4-yl|acetic acid derivatives
NL1015744C2 (nl) * 2000-07-19 2002-01-22 Dsm Nv Werkwijze voor de bereiding van 2-(6-gesubstitueerde-1,3-dioxan-4-yl) azijnzuurderivaten.
MXPA04000322A (es) 2001-07-13 2005-09-08 Astrazeneca Uk Ltd Preparacion de compuestos de aminopirimidina.
EP1323717A1 (en) 2001-12-27 2003-07-02 Dsm N.V. Process for the preparation of 2-(6-Substituted-1,3-Dioxane-4-yL) acetic acid derivatives
GB0211751D0 (en) * 2002-05-22 2002-07-03 Avecia Ltd Compound and process
EP1375493A1 (en) 2002-06-17 2004-01-02 Dsm N.V. Process for the preparation of an dioxane acetic acid ester
CA2492906A1 (en) * 2002-07-19 2004-01-29 Pascal Druzgala Materials and methods for treating hypercholesterolemia
GB0218781D0 (en) 2002-08-13 2002-09-18 Astrazeneca Ab Chemical process
ATE448209T1 (de) 2002-12-16 2009-11-15 Astrazeneca Uk Ltd Verfahren zur herstellung von pyrimidinverbindungen
GB0312896D0 (en) * 2003-06-05 2003-07-09 Astrazeneca Ab Chemical process
UY28501A1 (es) 2003-09-10 2005-04-29 Astrazeneca Uk Ltd Compuestos químicos
GB0324791D0 (en) * 2003-10-24 2003-11-26 Astrazeneca Ab Chemical process
GB0428328D0 (en) 2004-12-24 2005-02-02 Astrazeneca Uk Ltd Chemical process
GB0514078D0 (en) * 2005-07-08 2005-08-17 Astrazeneca Uk Ltd Chemical process
AT503017B1 (de) 2005-12-19 2007-07-15 Iep Gmbh Verfahren zur enantioselektiven enzymatischen reduktion von hydroxyketoverbindungen
KR20090083900A (ko) 2006-10-02 2009-08-04 코덱시스, 인코포레이티드 입체이성질체적으로 순수한 스타틴 및 이의 합성 중간체 제조용 조성물 및 제조 방법
TW200831469A (en) * 2006-12-01 2008-08-01 Astrazeneca Uk Ltd Chemical process
CN101624609B (zh) * 2009-07-31 2013-04-17 浙江九洲药业股份有限公司 酶催化制备(s)-3-取代戊二酸单酯类化合物的方法
US8093306B2 (en) * 2010-12-22 2012-01-10 Rentech, Inc. Integrated biorefinery for production of liquid fuels
US8168686B2 (en) 2010-12-22 2012-05-01 Rentech, Inc. Integrated biorefinery for production of liquid fuels
CN102373250B (zh) * 2011-11-08 2012-08-22 张家港市信谊化工有限公司 阿伐他汀钙侧链中间体的制备方法
CN102618596A (zh) * 2012-03-20 2012-08-01 中国药科大学 一种非水相体系中生物转化制备关附庚素的方法
WO2014203045A1 (en) 2013-06-20 2014-12-24 Lupin Limited A novel, green and cost effective process for synthesis of tert-butyl (3r,5s)-6-oxo-3,5-dihydroxy-3,5-o-isopropylidene-hexanoate
CN105503816B (zh) * 2016-02-17 2018-02-13 中节能万润股份有限公司 一种固体(4R‑cis)‑6‑甲酰基‑2,2‑二甲基‑1,3‑二氧己环‑4‑乙酸叔丁酯的制备方法
CN108530416B (zh) * 2017-11-02 2020-05-12 江苏阿尔法药业有限公司 一种瑞舒伐他汀中间体的制备方法
CN109574830B (zh) * 2019-01-04 2021-04-13 浙江宏元药业股份有限公司 一种瑞舒伐他汀钙中间体及其制备方法和应用
KR102384854B1 (ko) 2021-06-15 2022-04-11 한대성 풀빅산 및 일라이트를 이용한 침대

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB885516A (en) 1958-01-16 1961-12-28 Arthur Henry Clarkson Higher fatty acid esters of dextran
US3325466A (en) 1961-01-11 1967-06-13 American Cyanamid Co Tertiary butyl group as a carboxyl protecting group in the synthesis of peptides
GB1078709A (en) * 1965-10-14 1967-08-09 Lockspike Ltd Fastening members for securing railway rails and railway rail and fastening arrangements employing the fastening members
US3992432A (en) 1967-04-05 1976-11-16 Continental Oil Company Phase transfer catalysis of heterogeneous reactions by quaternary salts
JPS5559140A (en) * 1978-10-30 1980-05-02 Sankyo Co Ltd 3,5-dihydroxypentanoic alkyl ester derivative, its preparation and remedy for hyperlipemia containing the same as the effective component
GB9005966D0 (en) 1990-03-16 1990-05-09 May & Baker Ltd New compositions of matter
JP3097143B2 (ja) 1991-02-21 2000-10-10 チッソ株式会社 生理活性物質合成用光学活性化合物の製造法および光学活性中間体化合物
WO1993006235A1 (en) 1991-09-20 1993-04-01 Zeneca Limited Process for the preparation of enantiomerically pure 4-hydroxytetrahydro-2-pyranone derivatives
WO1993008823A1 (en) 1991-11-06 1993-05-13 Tanabe Seiyaku Co., Ltd. Guanidinyl and related cell adhesion modulation compounds
US5278313A (en) 1992-03-27 1994-01-11 E. R. Squibb & Sons, Inc. Process for the preparation of 1,3-dioxane derivatives useful in the preparation of HMG-COA reductase inhibitors
US5324662A (en) * 1992-05-15 1994-06-28 E. R. Squibb & Sons, Inc. Stereoselective microbial or enzymatic reduction of 3,5-dioxo esters to 3-hydroxy-5-oxo, 3-oxo-5-hydroxy, and 3,5-dihydroxy esters
EP0579370B1 (en) * 1992-06-10 2000-08-16 Chisso Corporation An optically active 1,5-disubstituted-2,4-0-isoproylidene-2,4-dihydroxypentane and a process for producing the same
JP3491296B2 (ja) * 1992-06-10 2004-01-26 チッソ株式会社 光学活性1、5−ジ置換−2、4−o−イソプロピリデン−2、4−ジヒドロキシペンタンおよびその製造法
JP3076154B2 (ja) 1992-08-13 2000-08-14 高砂香料工業株式会社 (3r,5s)−3,5,6−トリヒドロキシヘキサン酸誘導体及びその製造方法
JP3155107B2 (ja) * 1993-01-12 2001-04-09 ダイセル化学工業株式会社 光学活性4−ハロ−3−ヒドロキシ酪酸エステルの製造方法
US5795749A (en) 1995-04-05 1998-08-18 The Scripps Research Institution Use of 2-deoxyribose-5-phosphate aldolase to prepare 2-deoxyfucose, analogues and derivatives
JPH08336393A (ja) * 1995-04-13 1996-12-24 Mitsubishi Chem Corp 光学活性なγ−置換−β−ヒドロキシ酪酸エステルの製造法
GB9512837D0 (en) * 1995-06-23 1995-08-23 Zeneca Ltd reduction of ketone groups
GB9523924D0 (en) 1995-11-23 1996-01-24 Zeneca Ltd Production of optically active 2-substituted tetrahydropyran-4-ones
FR2741620B1 (fr) 1995-11-28 1997-12-26 Oreal Procede de preparation de composes a groupement beta-hydroxy -delta-lactone analogues de la (+) compactine et de la (+) mevinoline
US6278001B1 (en) * 1995-11-28 2001-08-21 L'oréal Method for preparing (+) compactin and (+) mevinolin analog compounds having a β-hydroxy-δ-lactone grouping
DE19610984A1 (de) * 1996-03-21 1997-09-25 Boehringer Mannheim Gmbh Alkohol-Dehydrogenase und deren Verwendung zur enzymatischen Herstellung chiraler Hydroxyverbindungen
JPH11187869A (ja) * 1997-12-25 1999-07-13 Daicel Chem Ind Ltd 新規な4−ハロアセト酢酸エステル還元酵素、該酵素の製造方法、及び該酵素を利用したアルコールの製造方法
US6344569B1 (en) 1998-04-30 2002-02-05 Kaneka Corporation Process for producing 6-cyanomethyl-1,3-dioxane-4-acetic acid derivatives
ATE266656T1 (de) 1998-08-05 2004-05-15 Kaneka Corp Verfahren zur herstellung optisch aktiver 2-(6- (hydroxymethyl)-1,3-dioxan-4-yl) -essigsäure- derivate
CZ299522B6 (cs) 1998-12-10 2008-08-27 Kaneka Corporation Zpusob výroby diolu obsahujícího laktonovou skupinu
DE19857302C2 (de) * 1998-12-14 2000-10-26 Forschungszentrum Juelich Gmbh Verfahren zur enantioselektiven Reduktion von 3,5-Dioxocarbonsäuren, deren Salze und Ester
GB9903472D0 (en) * 1999-02-17 1999-04-07 Zeneca Ltd Chemical process
HU227840B1 (en) 1999-05-06 2012-05-02 Egis Gyogyszergyar Nyilvanosan M Kod Ruszvunytarsasag Intermediates of atorvastatin synthesis and process for producing them
JP4659309B2 (ja) 1999-06-04 2011-03-30 株式会社カネカ 5−ヒドロキシ−3−オキソペンタン酸誘導体の製造法
WO2001004336A1 (de) * 1999-07-09 2001-01-18 Forschungszentrum Jülich GmbH Verfahren zur reduktion von keto-carbonsäuren und deren estern
AU2000254249A1 (en) 2000-03-28 2001-10-08 Biocon India Limited Synthesis of (r-(r*,r*))-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-
GB0011120D0 (en) 2000-05-09 2000-06-28 Avecia Ltd Process
CA2380997A1 (en) * 2000-06-05 2001-12-13 Kaneka Corporation Process for preparing optically active 2-¬6-(hydroxy-methyl)-1,3-dioxan-4-yl|acetic acid derivatives
NL1015744C2 (nl) * 2000-07-19 2002-01-22 Dsm Nv Werkwijze voor de bereiding van 2-(6-gesubstitueerde-1,3-dioxan-4-yl) azijnzuurderivaten.
MXPA04000322A (es) 2001-07-13 2005-09-08 Astrazeneca Uk Ltd Preparacion de compuestos de aminopirimidina.
EP1323717A1 (en) 2001-12-27 2003-07-02 Dsm N.V. Process for the preparation of 2-(6-Substituted-1,3-Dioxane-4-yL) acetic acid derivatives
CZ2004863A3 (cs) * 2002-02-25 2004-12-15 Biocon Limited Nové boranátové estery
KR100511533B1 (ko) 2002-04-09 2005-08-31 임광민 키랄 중간체, 그의 제조방법 및 그를 이용한 HMG-CoA환원저해제의 제조방법
EP1375493A1 (en) 2002-06-17 2004-01-02 Dsm N.V. Process for the preparation of an dioxane acetic acid ester
GB0218781D0 (en) * 2002-08-13 2002-09-18 Astrazeneca Ab Chemical process
ATE448209T1 (de) * 2002-12-16 2009-11-15 Astrazeneca Uk Ltd Verfahren zur herstellung von pyrimidinverbindungen
GB0312896D0 (en) 2003-06-05 2003-07-09 Astrazeneca Ab Chemical process
WO2004113314A1 (en) 2003-06-23 2004-12-29 Biocon Limited Novel boronate esters
UY28501A1 (es) 2003-09-10 2005-04-29 Astrazeneca Uk Ltd Compuestos químicos
GB0321827D0 (en) 2003-09-18 2003-10-15 Astrazeneca Uk Ltd Chemical compounds
GB0324791D0 (en) 2003-10-24 2003-11-26 Astrazeneca Ab Chemical process
JP4266879B2 (ja) 2004-05-12 2009-05-20 大阪瓦斯株式会社 ガス化炉及び複合リサイクル装置
US7161004B2 (en) * 2004-06-21 2007-01-09 Dr. Reddy's Laboratories Limited Processes to produce intermediates for rosuvastatin
GB0428328D0 (en) * 2004-12-24 2005-02-02 Astrazeneca Uk Ltd Chemical process
GB0514078D0 (en) 2005-07-08 2005-08-17 Astrazeneca Uk Ltd Chemical process
TW200831469A (en) * 2006-12-01 2008-08-01 Astrazeneca Uk Ltd Chemical process

Also Published As

Publication number Publication date
EP1282719A1 (en) 2003-02-12
PT1726658E (pt) 2010-04-15
CZ302674B6 (cs) 2011-08-24
ES2264981T3 (es) 2007-02-01
CA2677945A1 (en) 2001-11-15
US7888083B2 (en) 2011-02-15
US20080280336A1 (en) 2008-11-13
IL193405A0 (en) 2009-02-11
PL359336A1 (en) 2004-08-23
DE60129865T2 (de) 2008-05-08
DE60120685D1 (de) 2006-07-27
KR20030032949A (ko) 2003-04-26
MXPA02010955A (es) 2003-05-27
RU2266961C2 (ru) 2005-12-27
DE60120685T2 (de) 2007-06-14
EE05062B1 (et) 2008-08-15
CZ20023675A3 (cs) 2003-02-12
DK1726658T3 (da) 2010-05-17
PT1282719E (pt) 2006-09-29
PL208377B1 (pl) 2011-04-29
AU5238301A (en) 2001-11-20
PT1657310E (pt) 2007-09-26
CZ302675B6 (cs) 2011-08-24
IL193404A (en) 2010-04-29
DK1282719T3 (da) 2006-10-02
CY1106910T1 (el) 2012-09-26
KR100996977B1 (ko) 2010-11-26
ES2289722T3 (es) 2008-02-01
US7732171B2 (en) 2010-06-08
CY1109991T1 (el) 2014-09-10
US20030134900A1 (en) 2003-07-17
EP1282719B1 (en) 2006-06-14
PL208359B1 (pl) 2011-04-29
EE200200628A (et) 2004-04-15
PL208379B1 (pl) 2011-04-29
US7416865B2 (en) 2008-08-26
MY127751A (en) 2006-12-29
DE60129865D1 (de) 2007-09-20
UA73774C2 (en) 2005-09-15
BR0110667A (pt) 2003-03-25
DE60141424D1 (de) 2010-04-08
SK286746B6 (sk) 2009-04-06
IL193405A (en) 2010-04-29
CY1105376T1 (el) 2010-04-28
KR100914675B1 (ko) 2009-08-28
JP2003532427A (ja) 2003-11-05
HK1090090A1 (en) 2006-12-15
US7157255B2 (en) 2007-01-02
HK1096998A1 (en) 2007-06-15
CN1440461A (zh) 2003-09-03
SK287524B6 (sk) 2011-01-04
SI1726658T1 (sl) 2010-05-31
ZA200208937B (en) 2003-08-28
US20100209984A1 (en) 2010-08-19
SI1282719T1 (sl) 2006-10-31
EP1657310A1 (en) 2006-05-17
KR20080042129A (ko) 2008-05-14
SI1657310T1 (sl) 2007-12-31
EP1657310B1 (en) 2007-08-08
NO20025377L (no) 2003-01-07
IL193404A0 (en) 2009-02-11
ES2340190T3 (es) 2010-05-31
IL152608A0 (en) 2003-06-24
CZ302632B6 (cs) 2011-08-10
US20060194297A1 (en) 2006-08-31
EP1726658A3 (en) 2008-12-24
CA2408004A1 (en) 2001-11-15
AU2001252383B2 (en) 2005-04-14
AR070946A2 (es) 2010-05-19
CA2408004C (en) 2010-04-13
CN1196793C (zh) 2005-04-13
NO20025377D0 (no) 2002-11-08
ATE330020T1 (de) 2006-07-15
ATE369437T1 (de) 2007-08-15
EP1726658B1 (en) 2010-02-24
JP4733901B2 (ja) 2011-07-27
EP1726658A2 (en) 2006-11-29
IS6609A (is) 2002-11-07
SK15892002A3 (sk) 2003-04-01
HUP0302216A3 (en) 2011-03-28
AR028074A1 (es) 2003-04-23
TWI240753B (en) 2005-10-01
ATE458823T1 (de) 2010-03-15
IL152608A (en) 2009-05-04
WO2001085975A1 (en) 2001-11-15
HK1051708A1 (en) 2003-08-15
IS2290B (is) 2007-10-15
NZ522407A (en) 2004-06-25
HUP0302216A2 (hu) 2003-10-28
GB0011120D0 (en) 2000-06-28

Similar Documents

Publication Publication Date Title
DK1726658T3 (da) Fremgangsmåde til fremstilling af dihydroxyestere og derivater deraf
DK1292561T3 (da) Fremgangsmåde til fremstillingen af cyclopropylcarboxylsyreestere og -derivater
NO20030844L (no) Fremgangsmåte for fremstilling av N-aryl-antranilinsyrer og derivater derav
DK1323222T3 (da) Önet og fremgangsmåde til drift af et önet
DK2258688T3 (da) Pyridinon-derivater til behandling af aterosklerose
DK1044969T3 (da) Fremgangsmåde og mellemprodukter til fremstilling af anti-cancer forbindelser
DK1341414T3 (da) Marint actinomycet-taxon til opdagelse af medikamenter og fermenteringsprodukter
DK1334182T3 (da) Fremgangsmåde til fremstilling af ikke-bovint chymosin og anvendelse heraf
DK1296935T3 (da) Fremgangsmåde til fremstilling af substituerede octanoylamider
DK1265482T3 (da) Vandige formulationer og fremgangsmåde til fremstilling af samme
NO20015542L (no) Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner
DK1328538T3 (da) Fremgangsmåde og mellemprodukter til fremstilling af 7-substituerede antiöstrogener
DK1337547T3 (da) Nuklease-baseret fremgangsmåde til detektion og kvantificering af oligonukleotider
NO20003555L (no) Fremgangsmåte ved fremstilling av konstruksjonselementer og de resulterende elementer
DK1475379T3 (da) Anvendelse af scopinesterderivater til fremstilling af lægemidler
DK1339723T3 (da) Fremgangsmåde og ester derivater anvendelige til fremstilling af cefalosporiner
FI20000194A0 (fi) Menetelmä kaupankäynnissä
DK1341758T3 (da) Coniosetin og derivater af denne, fremgangsmåde til fremstilling og anvendelse af samme
DK1294694T3 (da) Fremgangsmåde til fremstilling af quinolinderivater
DK0899262T3 (da) Fremgangsmåde til fremstilling af heteroarylcarboxylamider og -estere
NO20030587L (no) Fremgangsmåte til fremstilling av diskodermolid og analoger derav
DK0930297T3 (da) Fremgangsmåde til fremstilling af naphtyridoner og mellemprodukter
DK1147074T3 (da) Fremgangsmåde til fremstilling af nitroxymethylphenylestere af aspirinderivater
DK1305326T3 (da) En forbedret fremgangsmåde til syntesen af sucrose-6-estere
DK1105101T3 (da) Fremgangsmåder og præparater til behandling af intracellulære infektioner